Skip to main content Deutsch


Thomas Bauer receives a Principal Investigator project from the Austrian Science Fund FWF

Medicine & Science, People of the MedUni Vienna

Thomas Bauer's research project "Defense Mechanisms during Microbial Hair Follicle Invasion" was approved for funding by the Austrian Science Fund…

Thomas Vogl receives Elisabeth Lutz Prize of the Academy of Sciences

Thomas Vogl, research group leader at MedUni Vienna's Center for Cancer Research, has been awarded the Elisabeth Lutz Prize by the Austrian Academy of…

Possible trigger of chronic inflammatory bowel disease identified

Medicine & Science

As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn's disease or ulcerative colitis is not yet known, treatment for sufferers is…

Juliane Winkler successful in WWTF Life Sciences 2023 call "Understanding Biology with AI/ML"

Medicine & Science, People of the MedUni Vienna

Juliane Winkler from the Center for Cancer Research was successful with her submission to the Life Sciences 2023 Call "Understanding Biology with…

FWF supports doctoral programs at the Medical University of Vienna

The Austrian Science Fund (FWF) awards grants within the 'doc.funds' and 'doc.funds.connect' programs to support doctoral programs, strengthening…

Thomas Vogl takes up tenure-track assistant professorship at MedUni Vienna

University, People of the MedUni Vienna

Thomas Vogl starts a §99-(5) Assistant Professorship in “Microbiome in Cancer Immunology” under the tenure-track model at the Medical University of…

Cancer Research Run 2023: 260,000 euros for research

A total of around 3,500 runners, including 86 companies with running teams, as sponsors or cooperation partners, supported cancer research at the…

Exploring new strategies for the development of platinum(IV) anticancer drugs

Recently published paper in Angewandte Chemie explores equatorial substitutions in platinum(IV) complexes.

Pleural mesothelioma: new therapeutic approach to enhance sensitivity to chemo- and radiotherapy

Medicine & Science

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options.

Europe-wide preclinical test platform for rare tumors in children established and secured for the future

Medicine & Science

The aim is tailored therapies for the most aggressive types of childhood cancer